{"id":112358,"date":"2020-09-02T22:26:02","date_gmt":"2020-09-03T05:26:02","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/09\/fda-approves-new-hiv-treatment-for-patients-with-limited-treatment-options"},"modified":"2020-09-02T22:26:02","modified_gmt":"2020-09-03T05:26:02","slug":"fda-approves-new-hiv-treatment-for-patients-with-limited-treatment-options","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/09\/fda-approves-new-hiv-treatment-for-patients-with-limited-treatment-options","title":{"rendered":"FDA Approves New HIV Treatment for Patients With Limited Treatment Options"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/fda-approves-new-hiv-treatment-for-patients-with-limited-treatment-options2.jpg\"><\/a><\/p>\n<p>Cross-posted from <a href=\"https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-hiv-treatment-patients-limited-treatment-options\">U.S. Food and Drug Administration<\/a><\/p>\n<p>[On July 2, 2020], the U.S. Food and Drug Administration approved Rukobia (fostemsavir), a new type of antiretroviral medication for adults living with HIV who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations.<\/p>\n<p>\u201cThis approval marks a new class of antiretroviral medications that may benefit patients who have run out of HIV treatment options,\u201d said Jeff Murray, M.D., deputy director of the Division of Antivirals in the FDA\u2019s Center for Drug Evaluation and Research. \u201cThe availability of new classes of antiretroviral drugs is critical for heavily treatment-experienced patients living with multidrug resistant HIV infection\u2014helping people living with hard-to-treat HIV who are at greater risk for HIV-related complications, to potentially live longer, healthier lives.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Cross-posted from U.S. Food and Drug Administration [On July 2, 2020], the U.S. Food and Drug Administration approved Rukobia (fostemsavir), a new type of antiretroviral medication for adults living with HIV who have tried multiple HIV medications and whose HIV infection cannot be successfully treated with other therapies because of resistance, intolerance or safety considerations. [\u2026]<\/p>\n","protected":false},"author":513,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-112358","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/112358","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/513"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=112358"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/112358\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=112358"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=112358"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=112358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}